Stryker Corporation (SYK)
NYSE: SYK · Real-Time Price · USD
364.02
-0.33 (-0.09%)
At close: Dec 5, 2025, 4:00 PM EST
366.98
+2.96 (0.81%)
After-hours: Dec 5, 2025, 7:34 PM EST
Stryker Market Cap
Stryker has a market cap or net worth of $139.21 billion as of December 5, 2025. Its market cap has decreased by -6.22% in one year.
Market Cap
139.21B
Enterprise Value
153.00B
1-Year Change
-6.22%
Ranking
Category
Stock Price
$364.02
Market Cap Chart
Since December 1, 1998, Stryker's market cap has increased from $4.26B to $139.21B, an increase of 3,171.06%. That is a compound annual growth rate of 13.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 139.34B | 1.51% |
| Dec 31, 2024 | 137.26B | 20.65% |
| Dec 29, 2023 | 113.76B | 22.96% |
| Dec 30, 2022 | 92.52B | -8.29% |
| Dec 31, 2021 | 100.88B | 9.55% |
| Dec 31, 2020 | 92.08B | 17.16% |
| Dec 31, 2019 | 78.59B | 34.00% |
| Dec 31, 2018 | 58.65B | 1.22% |
| Dec 29, 2017 | 57.95B | 29.16% |
| Dec 30, 2016 | 44.86B | 28.54% |
| Dec 31, 2015 | 34.90B | -2.20% |
| Dec 31, 2014 | 35.69B | 25.51% |
| Dec 31, 2013 | 28.43B | 36.42% |
| Dec 31, 2012 | 20.84B | 9.57% |
| Dec 30, 2011 | 19.02B | -10.80% |
| Dec 31, 2010 | 21.33B | 6.45% |
| Dec 31, 2009 | 20.03B | 24.21% |
| Dec 31, 2008 | 16.13B | -47.41% |
| Dec 31, 2007 | 30.67B | 36.69% |
| Dec 29, 2006 | 22.44B | 24.71% |
| Dec 30, 2005 | 17.99B | -7.24% |
| Dec 31, 2004 | 19.40B | 14.38% |
| Dec 31, 2003 | 16.96B | 27.63% |
| Dec 31, 2002 | 13.29B | 15.78% |
| Dec 31, 2001 | 11.48B | 15.98% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |